Current FDA status Semaglutide (Ozempic/Wegovy) is patent-protected by Novo Nordisk (29 patents) until at least 2026
Heavier or Lighter Bleeding: Semaglutide may also impact the flow of menstrual blood, leading to changes in bleeding patterns
Signs you may need a dose adjustment Contact your healthcare provider if you notice any of the following: Persistent mood changes or low energy after several weeks Ongoing side effects like insomnia, nausea, or restlessness Little or no change in appetite or weight despite consistent use (when using for off-label weight loss)
Most affordable + predictable: plan pricing is published before checkout, with same-price-at-every-dose messaging for the all-inclusive plan pages
Heres what sets InjectCo apart as a physician-guided online weight loss program supported by licensed healthcare professionals
Many people who take semaglutide, especially those who adopt lifestyle changes, can maintain their ideal weight with the lowest effective dose of the medication
